Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: A possible intermediate neurobiological phenotype

Biological Psychiatry

Volumn 44, Issue 10, 1998, Pages 941-950

  Callicott, Joseph H ^a   Egan, Michael F ^a   Bertolino, Alessandro ^a   Mattay, Venkata S ^a   Langheim, Frederick J P ^a   Frank, Joseph A ^b   Weinberger, Daniel R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Endophenotype; Glutamate; Prefrontal; Schizophrenia; Sibling; Spectroscopy

Indexed keywords

CHOLINE; CREATINE; CREATINE PHOSPHATE; GLUTAMIC ACID; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC SUSCEPTIBILITY; HIPPOCAMPUS; HUMAN; MENTAL DISEASE; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOSIS; RISK ASSESSMENT; SCHIZOPHRENIA; SIBLING;

ADULT; ASPARTIC ACID; BIOLOGICAL MARKERS; CHOLINE; CREATINE; FAMILY; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PHENOTYPE; PHOSPHOCREATINE; PREFRONTAL CORTEX; RISK; SCHIZOPHRENIA;

EID: 0032533636     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00264-9     Document Type: Article

References (72)

1. Arolt V., Lencer R., Nolte A., Muller-Myhsok B., Purman S., Schurmann M., et al. Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease. Am J Med Genet. 67:1996;564-579.
2. Austin S.J., Connelly A., Gadian D.G., Benton J.S., Brett E.M. Localized 1H NMR spectroscopy in Canavan's disease A report of two cases . Magn Reson Med. 19:1991;439-445.
3. Baron M. Genetic linkage and mental disorders An update on analytical methodologies [editorial] . Biol Psychiatry. 36:1994;1-4.
4. Bartko J.J., Carpenter W.T. On the methods and theory of reliability. J Nerv Ment Dis. 163:1976;307-317.
5. Bertolino A., Nawroz S., Mattay V., Barnett A., Duyn J., Moonen C., et al. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry. 153:1996;1554-1563.
6. Bertolino A., Saunders R., Mattay V., Bachevalier J., Frank J., Weinberger D. Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions A proton magnetic resonance spectroscopic imaging study . Cereb Cortex. 7:1997;740-748.
7. Bertolino A, Knable MB, Callicott JH, Heinz A, Mattay VS, Kotrla K, et al (1997): Prefrontal cortical regulation of subcortical dopamine in patients with schizophrenia: A 1H-magnetic spectroscopic imaging and IBZM-SPECT study. Proceedings of the 27th Annual Meeting of the Society for Neuroscience, Oct. 25-30, 1997, New Orleans, LA. Washington, D.C.: Society for Neuroscience, p 846.
8. Bertolino A., Esposito G., Callicott J.H., Mattay V.S., Horn J.D.V., Frank J.A., et al. 1H-Magnetic spectroscopic imaging correlates with rCBF activation during working memory in patients with schizophrenia. Neuroimage. 5:1997;S281.
9. Bertolino A., Callicott J.H., Ellman I., Mattay V.S., Tedeschi G., Frank J.A., et al. Regionally specific neuronal pathology in untreated patients with schizophrenia: A proton magnetic resonance spectroscopic imaging study. Biol Psychiatry. 43:1998;641-648.
10. Bertolino A., Callicott J.H., Nawroz S., Mattay V.S., Duyn J.H., Tedeschi G., et al. Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia. Neuropsychopharmacology. 18:1998;1-8.
11. Bertolino A, Kumra S, Callicott JH, Mattay VS, Letsz RM, Barnett AS, et al (in press): A common pattern of cortical pathology in childhood onset and adult onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging. Am J Psychiatry.
12. Blackwood D.H.R., St Clair D.M., Muir W.J., Duffy J.C. Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees. Arch Gen Psychiatry. 48:1991;899-909.
13. Blackwood D.H.R., Ebmeier K.P., Muir W.J., Sharp C.W., Glabus M., Walker M., et al. Correlation of regional cerebral blood flow equivalents measured by single photon emission computerized tomography with P300 latency and eye movement abnormality in schizophrenia. Acta Psychiatr Scand. 90:1994;157-166.
14. Buckley P.F., Moore C., Long H., Larkin C., Thompson P., Mulvany F., et al. 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia Clinical, neurodevelopmental, cognitive correlates . Biol Psychiatry. 36:1994;792-800.
15. Burke J.G., Murphy B.M., Bray J.C., Walsh D., Kendler K.S. Clinical similarities in siblings with schizophrenia. Am J Med Genet. 67:1996;239-243.
16. Cannon T.D., Zorrilla L.E., Shtasel D., Gur R.E., Gur R.C., Marco E.J., et al. Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers. Arch Gen Psychiatry. 51:1994;651-661.
17. Clementz B.A., Sweeney J.A. Is eye movement a biological marker for schizophrenia? A methodological review. Psychol Bull. 108:1990;77-92.
18. Crowe R.R. Candidate genes in psychiatry: An epidemiological perspective. Am J Med Genet. 48:1993;74-77.
19. Deicken R.F., Zhou L., Corwin F., Vinogradov S., Weiner M.W. Decreased frontal lobe N-acetylaspartate in schizophrenia. Am J Psychiatry. 154:1997;688-690.
20. DeLisi L.E., Goldin L.R., Hamovit J.R., Maxwell M.E., Kurtz D., Gershon E.S. A family study of the association of increased ventricular size in schizophrenia. Arch Gen Psychiatry. 43:1986;148-153.
21. DeLisi L.E., Goldin L.R., Gershon E.S. Studies of biological factors associated with the inheritance of schizophrenia: A selective review. J Psychiatr Res. 21:1987;507-513.
22. Duyn J., Gillen J., Sobering G., Van Z.P., Moonen C. Multisection proton MR spectroscopic imaging of the brain. Radiology. 188:1993;277-282.
23. Egan M.F., Weinberger D.R. Neurobiology of schizophrenia. Curr Opin Neurobiol. 17:1997;701-707.
24. Faraone S.V., Kremen W.S., Lyons M.J., Pepple J.R., Seidman L.J., Tsuang M.T. Diagnostic accuracy and linkage analysis How useful are schizophrenia spectrum phenotypes? Am J Psychiatry. 152:1995;1286-1290.
25. Finkelstein J.R., Cannon T.D., Gur R.E., Gur R.C., Moberg P. Attentional dysfunctions in neuroleptic-naive and neuroleptic-withdrawn schizophrenic patients and their siblings. J Abnorm Psychol. 106:1997;203-212.
26. First MB, Spitzer RL, Gibbon M, Williams JB (1995): The Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, Version 2.0) New York: New York State Psychiatric Institute.
27. Franke P., Maier W., Hain C., Klingler T. Wisconsin card sorting test An indicator of vulnerability to schizophrenia? Schizophr Res. 6:1992;243-249.
28. Freedman R., Waldo M., Bickford-Wilmer P., Nagamoto H. Elementary neuronal dysfunctions in schizophrenia. Schizophr Res. 4:1991;233-243.
29. Freedman R., Coon H., Myles-Worsley M., Orr-Urteger A., Olincy A., Davis A., et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA. 94:1997;587-592.
30. Goldberg T.E., Ragland J.D., Torrey E.F., Bigelow L.B., Gold J.M., Weinberger D.R. Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry. 47:1990;1066-1072.
31. Goldberg T.E., Torrey E.F., Gold J.M., Ragland J.D., Bigelow L.B., Weinberger D.R. Learning and memory in monozygotic twins discordant for schizophrenia. Psychol Med. 23:1993;71-85.
32. Goldberg T.E., Torrey E.F., Berman K.F., Weinberger D.R. Relations between neuropsychological performance and brain morphological and physiological measures in monozygotic twins discordant for schizophrenia. Psychiatry Res. 55:1994;51-61.
33. Green M.F., Nuechterlein K.H., Breitmeyer B. Backward masking performance in unaffected siblings of schizophrenic patients. Evidence for a vulnerability indicator. Arch Gen Psychiatry. 54:1997;465-472.
34. Hain C., Maier W., Hoechst-Janneck S., Franke P. Subclinical thought disorder in first-degree relatives of schizophrenic patients. Results from a matched-pairs study with the thought disorder index. Acta Psychiatr Scand. 92:1995;305-309.
35. Holzman P.S. Behavioural markers of schizophrenia useful for genetic studies. J Psychiatr Res. 26:1982;427-445.
36. Holzman P.S. The role of psychological probes in genetic studies of schizophrenia. Schizophr Res. 13:1994;1-9.
37. Holzman P.S., Solomon C.M., Levin S., Waternaux C.S. Pursuit eye movement dysfunction in schizophrenia. Family evidence for specificity. Arch Gen Psychiatry. 41:1984;136-139.
38. Kaul R., Balamurugan K., Gao G.P., Matalon R. Canavan disease Genomic organization and localization of human ASPA to 17p13-ter and conservation of the ASPA gene during evolution . Genomics. 21:1994;364-370.
39. Kidd K.K. Can we find genes for schizophrenia? Am J Med Genet. 74:1997;104-111.
40. Levy D., Holzman P.S., Matthysse S., Mendell N.R. Eye tracking dysfunction and schizophrenia A critical perspective . Schizophr Bull. 19:1993;461-536.
41. Liddle P. Brain imaging. Hirsch S., Weinberger D. Schizophrenia. 1995;425-439 Blackwood Press, London.
42. Lipska B.K., Jaskiw G.E., Weinberger D.R. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: A potential animal model of schizophrenia. Neuropsychopharmacology. 9:1993;67-75.
43. MacAvoy M.G., Bruce C.J. Comparison of the smooth eye tracking disorder of schizophrenics with that of nonhuman primates with specific brain lesions. Int J Neurosci. 80:1995;117-151.
44. Maier M., Ron M., Barker G., Tofts P. Proton magnetic resonance spectroscopy An in-vivo method of estimating hippocampal neuronal depletion in schizophrenia . Psychol Med. 25:1995;1201-1209.
45. Nasrallah H.A., Skinner T.E., Schmalbrock P., Robitaille P.M. Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia A pilot study . Br J Psychiatry. 165:1994;481-485.
46. Oldfield R.C. The assessment and analysis of handedness The Edinburgh inventory . Neuropsychologia. 9:1971;97-113.
47. O'Rourke D.H., Gottesman I.I., Suarez B.K., Rice J., Reich T. Refutation of the general single-locus model for the etiology of schizophrenia. Am J Hum Genet. 34:1982;630-649.
48. Park S., Holzman P.S., Goldman-Rakic P.S. Spatial working memory deficits in the relatives of schizophrenic patients. Arch Gen Psychiatry. 52:1995;821-828.
49. Renshaw P., Yurgelun-Todd D., Tohen M., Gruber S., Cohen B. Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. Am J Psychiatry. 152:1995;444-446.
50. Risch N. Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet. 46:1990;222-228.
51. Risch N. Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet. 46:1990;229-241.
52. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science. 273:1996;1516-1517.
53. Roxborough H., Muir W.J., Blackwood D.H., Walker M.T., Blackburn I.M. Neuropsychological and P300 abnormalities in schizophrenics and their relatives. Psychol Med. 23:1993;305-314.
54. Saunders R.C., Kolachana B.S., Bachevalier J., Weinberger D.R. Neonatal lesions of medial temporal lobe disrupt prefrontal cortical regulation of striatal dopamine. Nature. 393:1998;169-171.
55. Shedlack K., Lee G., Sakuma M., Xie S.-H., Kushner M., Pepple J., et al. Language processing and memory in ill and well siblings from multiplex families affected with schizophrenia. Schizophr Res. 25:1997;43-52.
56. Shihabuddin L., Silverman J.M., Buchsbaum M.S., Seiver L.J., Luu C., Germans M.K., et al. Ventricular enlargement associated with linkage marker for schizophrenia-related disorders in one pedigree. Mol Psychiatry. 1:1996;215-222.
57. Siegel C., Waldo M., Mizner G., Adler L.E., Freedman R. Deficits in sensory gating in schizophrenic patients and their relatives. Arch Gen Psychiatry. 41:1984;607-612.
58. Siever L.J., Coursey R.D. Biological markers for schizophrenia and the biological high-risk approach. J Nerv Ment Dis. 173:1985;4-16.
59. Spring B.J. Shift of attention in schizophrenics, siblings of schizophrenics, and depressed patients. J Nerv Ment Dis. 168:1980;133-140.
60. Tedeschi G., Bertolino A., Righini A., Campbell G., Raman R., Duyn J.H., et al. Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging. Neurology. 45:1995;1384-1391.
61. Tsai G., Coyle J.T. N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol. 46:1995;531-540.
62. Tsai G., Passani L.A., Slusher B.S., Carter R., Baer L., Kleinman J.E., et al. Abnormal excitatory neurotransmitter metabolism in schizophrenic brain. Arch Gen Psychiatry. 52:1995;829-836.
63. Weinberger D.R. Anteromedial temporal-prefrontal connectivity A functional neuroanatomical system implicated in schizophrenia . Carroll B.J., Barrett J.E. Psychopathology and the Brain. 1991;25-43 Raven Press, New York.
64. Weinberger D.R. A connectionist approach to the prefrontal cortex. J Neuropsychiatry. 5:1993;241-253.
65. Weinberger D.R. Schizophrenia as a neurodevelopmental disorder A review of the concept . Hirsch S.R., Weinberger D.R. Schizophrenia. 1995;293-323 Blackwood Press, London.
66. Weinberger D.R., Berman K.F. Prefrontal function in schizophrenia Confounds and controversies . Phil Trans R Soc Med. 351:1996;1495-1503.
67. Weinberger D.R., Lipska B.K. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia A search for common ground . Schizophr Res. 16:1995;87-110.
68. Weinberger D.R., DeLisi L.E., Neophytides A.N., Wyatt R.J. Familial aspects of CT scan abnormalities in chronic schizophrenic patients. Psychiatry Res. 4:1981;65-71.
69. Wittsack H.J., Kugel H., Roth B., Heindel W. Quantitative measurements with localized 1H MR spectroscopy in children with Canavan's disease. J Magn Reson Imaging. 6:1996;889-893.
70. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 19:1955;251-253.
71. Yurgelun-Todd D.A., Kinney D.K. Patterns of neuropsychological deficits that discriminate schizophrenic individuals from siblings and control subjects. J Neuropsychiatry Clin Neurosci. 5:1993;294-300.
72. Yurgelun-Todd D., Renshaw P., Gruber S., Waternaux C., Cohen B. Proton magnetic resonance spectroscopy of patients with first-episode psychosis. Schizophr Res. 152:1996;444-446.